Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - PharMerica CORPFinancial_Report.xls
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 - PharMerica CORPd335783dex312.htm
EX-32.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 906 - PharMerica CORPd335783dex322.htm
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 - PharMerica CORPd335783dex311.htm
EX-10.39 - SUMMARY OF 2012 LONG-TERM INCENTIVE PROGRAM - PharMerica CORPd335783dex1039.htm
EX-10.38 - SUMMARY OF 2012 CEO SHORT-TERM INCENTIVE PROGRAM - PharMerica CORPd335783dex1038.htm
10-Q - FORM 10-Q - PharMerica CORPd335783d10q.htm

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of PharMerica Corporation (the “Corporation”) on Form 10-Q for the quarter ended March 31, 2012 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Gregory S. Weishar, Chief Executive Officer and Director of the Corporation, certify, pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Corporation.

 

/s/ GREGORY S. WEISHAR

Gregory S. Weishar

Chief Executive Officer and Director

May 2, 2012